Journal of International Business and Law Volume 15 | Issue 1 Article 6 1-1-2015 China's Healthcare Reform: How Patent Laws and Generic Drugs Can Benefit hinC a's Public Health Patrick Russo Follow this and additional works at: http://scholarlycommons.law.hofstra.edu/jibl Part of the Health Law and Policy Commons Recommended Citation Russo, Patrick (2015) "China's Healthcare Reform: How Patent Laws and Generic Drugs Can Benefit hinC a's Public Health," Journal of International Business and Law: Vol. 15: Iss. 1, Article 6. Available at: http://scholarlycommons.law.hofstra.edu/jibl/vol15/iss1/6 This Notes & Student Works is brought to you for free and open access by Scholarly Commons at Hofstra Law. It has been accepted for inclusion in Journal of International Business and Law by an authorized administrator of Scholarly Commons at Hofstra Law. For more information, please contact
[email protected]. Russo: China's Healthcare Reform: How Patent Laws and Generic Drugs Can CHINA'S HEALTHCARE REFORM: HOW PATENT LAWS AND GENERIC DRUGS CAN BENEFIT CHINA'S PUBLIC HEALTH Patrick Russo CHINA'S HEALTHCARE ISSUES Imagine a place where a sick or disabled child is quickly disowned by his parents and handed over to the government. Imagine a medical care system that forces a father to abandon his three-month-old daughter in front of an orphanage at six in the morning. Imagine a government that purposely establishes drop-off centers for medically adverse children because their parents are financially unable to care for them. Surely, no such place could exist, right? It just so happens that the world's most populous country, and the largest economy, is currently facing this dilemma.' Late afternoon in the Sichuan province of China, a young, 21-year-old father holds his newborn son in one arm, and all the infant's cloths and belongings in a bag in the other arm.